{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-104291","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2026-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.533071+00:00","generated_at":"2026-05-15T12:54:02.698897+00:00","sec_items":["5.08","8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"confidence":"low","headline":"Plus Therapeutics sets 2026 annual meeting for May 14; proxy deadlines March 22","bullets":["Annual meeting scheduled for May 14, 2026 at 9:00 a.m. ET, held virtually.","Record date for stockholders is March 18, 2026.","Deadline for Rule 14a-8 stockholder proposals and director nominations: March 22, 2026.","Meeting date is more than 30 days before 2025 anniversary, rendering prior proxy deadlines void.","Universal proxy rule compliance notice also due by March 22, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-104291","json":"https://secwatch.observer/filing/0001193125-26-104291.json","markdown":"https://secwatch.observer/filing/0001193125-26-104291.md","text":"https://secwatch.observer/filing/0001193125-26-104291.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526104291/0001193125-26-104291-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526104291/pstv-20260311.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T12:54:02.698897+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}